Systemic Oral Glucocorticoids for the Treatment of Acute Osteoarthritis Pain in the Emergency Department
for Osteoarthritis
1 location in York
Sponsor: WellSpan Health
Sex: All·Age: 18+
Code: NCT06603662·Phase 4·Recruiting·Listed Sep 2024
Paid Clinical Trials in York, PA
As of August 2026, 95 paid clinical trials are recruiting in York, Pennsylvania. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
91 clinical trials
Customized TULSA-PRO Ablation Registry
for Prostate Cancer
Sites in York +4 more locations
Sponsor: Profound Medical Inc.
Sex: Male·Age: 18+
Code: NCT05001477·Recruiting·Listed Aug 2021
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
for Acute Ischemic Stroke
Sites in York, Pittsburgh +49 more locations
Sponsor: Mercy Health Ohio
Sex: All·Age: 18 - 79
Code: NCT05611242·Phase 3·Recruiting·Listed Nov 2022
Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers
for Endometrial Cancer
1 location in York
Sponsor: WellSpan Health
Sex: Female·Age: 18+
Code: NCT04570553·Recruiting·Listed Sep 2020
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
for Gastric Cancer
Drug: Sonesitatug vedotin
Sites in York, Hershey +70 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT07431281·Phase 3·Recruiting·Listed Feb 2026
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
for Epithelial Ovarian Cancer
Sites in York +38 more locations
Sponsor: AstraZeneca
Sex: Female·Age: 18+
Code: NCT07218809·Phase 3·Recruiting·Listed Oct 2025
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
for Endometrial Cancer
Sites in York, Hershey +65 more locations
Sponsor: AstraZeneca
Sex: Female·Age: 18+
Code: NCT07044336·Phase 3·Recruiting·Listed Jun 2025
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
for Locally Advanced Head and Neck Squamous Cell Carcinoma
Sites in York, Pittsburgh +44 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18 - 130
Code: NCT06129864·Phase 3·Recruiting·Listed Nov 2023
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
for Non-small Cell Lung Cancer
Drug: Rilvegostomig
Sites in York, Hershey +61 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT06692738·Phase 3·Recruiting·Listed Nov 2024
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC
for Non-squamous Non-small Cell Lung Cancer
Drug: Rilvegostomig
Sites in York +60 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT06627647·Phase 3·Recruiting·Listed Oct 2024
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
for Breast Cancer, Early Breast Cancer
Drug: Camizestrant
Sites in York, Gettysburg +102 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18 - 130
Code: NCT05952557·Phase 3·Recruiting·Listed Jul 2023